;){kind=link}
Mr. Fisher Tan
Manager
Overseas Department
Address:
36floor Unite D1, Kexing Science Park, Keyuan Road, Nanshan District, Shenzhen, Guangdong, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2019
Business Range:
Chemicals
Management System Certification:
ISO 20000, GMP
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
Shenzhen Kexing Biotech Co., Ltd. is the first Biopharmaceutical enterprise in China, since founded in 1989, takes the improvement of China bioengineering Industry as its mission. Kexing Biotech is the first "863 Program" High-tech Industrialization Base, the largest Industrialization base of genetic pharmaceuticals in China.
The hit product of the company-SINOGEN (Recombinant Human ...
The hit product of the company-SINOGEN (Recombinant Human ...
Shenzhen Kexing Biotech Co., Ltd. is the first Biopharmaceutical enterprise in China, since founded in 1989, takes the improvement of China bioengineering Industry as its mission. Kexing Biotech is the first "863 Program" High-tech Industrialization Base, the largest Industrialization base of genetic pharmaceuticals in China.
The hit product of the company-SINOGEN (Recombinant Human Interferon α 1b) becoming the interferon product
With most specifications. SINOGEN is the first position of Curative effect, frequency of use, market share, popularity,
And fame at home and abroad, becoming the first brand Of China interferon market. The company's new pharmaceutical base was Completed in 2012, and the new GMP certification was Adopted at the end of 2013, Interferon capacity has Increased to 25 million a year.
The hit product of the company-SINOGEN (Recombinant Human Interferon α 1b) becoming the interferon product
With most specifications. SINOGEN is the first position of Curative effect, frequency of use, market share, popularity,
And fame at home and abroad, becoming the first brand Of China interferon market. The company's new pharmaceutical base was Completed in 2012, and the new GMP certification was Adopted at the end of 2013, Interferon capacity has Increased to 25 million a year.
International Commercial Terms(Incoterms):
FOB, CFR, CIF, CIP, FCA, EXW
Terms of Payment:
LC, T/T
Average Lead Time:
Peak Season Lead Time: within 15 workdays, Off Season Lead Time: within 15 workdays
Number of Foreign Trading Staff:
11~20 People
Export Year:
2019-11-14
Export Percentage:
51%~70%
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia
Nearest Port:
shenzhen port
Factory Address:
36floor Unite D1, Kexing Science Park, Keyuan Road, Nanshan District, Shenzhen, Guangdong, China
R&D Capacity:
Own Brand(kexing)
No. of R&D Staff:
Above 50 People
No. of Production Lines:
10
Annual Output Value:
Above US$100 Million